Autoimmune Disease Diagnostics Market Size, Growth, Trends, Share and Analysis

Autoimmune Disease Diagnostics Market

Market Overview

The autoimmune disease diagnostics market is estimated to register a CAGR of nearly 7.9% during the forecast period, 2019-2024.

• Globally, increasing awareness of autoimmune diseases through research, education, support, and advocacy programs is a key factor boosting the rates of use of autoimmune disease diagnostics.

• The US has the highest incidence of autoimmune diseases, with approximately 50 million patients suffering from autoimmune diseases.

• In 2017, approximately 54.4 million people in the United States suffer from diagnosed arthritis, according to the Arthritis Foundation.

• According to the International Diabetes Federation IDF s 2017 report, approximately 425 million adults 20-79 years had diabetes, and by 2045 this number could rise to 629 million worldwide.

• Government organizations and NGOs aim to raise awareness of the socioeconomic impact of autoimmunity by promoting and facilitating effective, ethical and efficient collaboration in the fields of education, public awareness, research and patient services.

• Other factors, such as improved laboratory automation, partnerships with doctors and clinical laboratories, and advances in technology, are driving the diagnostics market for autoimmune disease. However, the diagnostic slow turnaround time and high frequency of false results hinder the growth of the diagnostic market for autoimmune disease.

Get a Free Sample Copy of this Report @ https://www.planetmarketreports.com/report-sample/autoimmune-disease-diagnostics-market

Report Portfolio

Autoimmunity involves the loss of normal immune homeostasis as an abnormal response to the organisms own tissue. Autoimmune diseases are usually associated with the presence of self-reactive T cells, autoantibodies, and inflammation. It is very difficult to diagnose potential autoimmune diseases because not one single laboratory test alone can produce diagnostic results for the disease. Therefore, there is a need for multiple laboratory tests, including basic studies such as complete blood count, comprehensive metabolic panel, acute phase reactants, immunological studies, serologies, flow cytometry, cytokine analysis and HLA type. While some tests may be non-specific, such as erythrocyte sedimentation rate ESR , they are useful for evaluating the activity of the disease. These tests can be useful in diagnosing and managing patients suffering from autoimmune diseases and can help to provide a prognosis or to indicate the severity of the involvement or damage of the organ.

Key Market Trends

Immunologic Assays Segment Leads the Autoimmune Disease Diagnostics Market

The diagnostic market for autoimmune disease is segmented by type of disease and diagnosis. Again, diagnosis is segmented into regular laboratory tests, inflammatory markers, immunological tests, antibody tests, and other tests.

The segment of immunological assays is expected to record a healthy CAGR during the forecast period. The factors responsible for this markets growth include cost-effectiveness, growth in the biotechnology and pharmaceutical industries, and high sensitivity and immunoassay specificity. Immunological assays have been proven to provide highly accurate results compared to conventional tests, even with very small samples. Immunological reactions are highly specific as they can only occur when proper immunological agents are present. For example, a viral protein antibody cannot bind with a bacteria-derived antigen. This high specificity indicates high results accuracy, allowing for high sensitivity in disease detection. Not only does this high sensitivity help with easy detection, it also eliminates the need for secondary verifications, which ultimately saves costs. For example, in December 2018, Quidel received a CE mark approval for use with the Sofia 2 Fluorescent Immunoassay Analyzer for its Quidel product Sofia 2 Lyme+ FIA.

Asia-Pacific is the Fastest Growing Region in the Autoimmune Disease Diagnostics Market

Due to rising disposable income and increasing patient pool in the emerging countries, Asia-Pacific is expected to show significant market growth over the forecast period. In addition, increased awareness of the advantages of early and precise diagnosis of autoimmune diseases to seek proper therapy, increased healthcare infrastructure development, and increased healthcare expenditure are likely to increase growth in the Asia-Pacific regions autoimmune diagnostics industry.

The Japanese autoimmune disease diagnostics market holds the largest market share in the Asia-Pacific region and has registered a healthy CAGR since 2017, due to the presence of a large population with the countrys autoimmune condition. Growth strategies adopted by local and international players in the Asia-Pacific region also drive growth in the diagnostic market for autoimmune disease. In 2017, ImmunArray, a private-owned diagnostic company for molecular devices, and Kindstar Global Co. Because of the increasing prevalence of the disease in China, Ltd, a specialty clinical testing company based in Wuhan, forged a partnership to undertake joint clinical lupus tests.

Get More Information about this Report and TOC @ https://www.planetmarketreports.com/reports/autoimmune-disease-diagnostics-market

Competent Landscape

The market is made up of major players on the market, and these players focus on R&D activities and significant strategies for growth. A couple of diagnostic companies have recently entered into strategic hospital partnerships. In order to meet the high volume of patient needs across different regions, this trend is expected to continue over the coming years.

• July 2017: AARDA hosted the first Bowling Green Autoimmune Walk and Warriors 5 K Fun Run in collaboration with the Relapsing Polychondritis Awareness & Support Foundation RPASF .

• May 2017: Patheon was acquired by Thermo Fisher Scientific.

• June 2017: Abbott introduced the Alinity HG hematology analyzer, the newest addition to the harmonized systems family of Alinity.

• June 2017: Bio-Rad signed a full-automated IFA slide processing and reading system agreement with VISIA Imaging.

Thus, over the past couple of years, the market has witnessed technological developments on a large scale.

About Us: –

Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision-making process. We have a huge database of market research reports & company profiles across the globe.  We offer premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Planet Market Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, & industry experts which provide you deeper penetration of market research industry ensuring you will receive the most reliable and up to date research data available.

Name: Jennifer Daniel
Email-Id: sales@planetmarketreports.com
US: +1-716-2260907
UK: +447441952057
Organization: Planet Market Reports